ICD-10-CM Billable Code

Z85.71

Personal history of Hodgkin lymphoma

Clinical Classification Guidelines

Inclusion Terms

  • Conditions classifiable to C81

Medical Intelligence & Overview

ICD-10 code Z85.71 refers to a patient's history of Hodgkin lymphoma, a type of lymphoma or blood cancer originating from a specific kind of white blood cells called lymphocytes. This code is used when documenting a patient's medical history to indicate they previously experienced Hodgkin lymphoma but may no longer have active disease. Recognizing and recording this history is vital for ongoing healthcare management, as prior lymphoma can influence future medical decisions and screenings.

Causes & Symptoms

Clinical Causes: Hodgkin lymphoma develops due to a combination of genetic and environmental factors. While the exact cause remains unknown, several risk factors have been identified: - **Genetic predisposition:** A family history of lymphoma or other blood cancers - **Age:** Commonly diagnosed in young adults aged 15-35 and older adults over 55 - **Gender:** Slightly more common in males - **Weakened immune system:** Due to diseases like HIV/AIDS or immunosuppressive therapy - **Infections:** History of infections such as Epstein-Barr virus (EBV) or certain other viruses - **Environmental exposures:** Exposure to certain chemicals or toxins It's important to note that these factors increase risk but do not directly cause Hodgkin lymphoma.

Key Symptoms: Individuals with Hodgkin lymphoma may experience a variety of symptoms, which can vary among patients. Common signs include: - **Painless swelling of lymph nodes:** Especially in the neck, armpits, or groin - **Fever:** Persistent or intermittent - **Night sweats:** Often drenching - **Weight loss:** Without intentional dieting - **Fatigue:** Extreme tiredness or lack of energy - **Itching:** Generalized or localized - **Persistent cough or chest pain:** If the lymphoma involves mediastinal lymph nodes These symptoms can resemble other illnesses, emphasizing the importance of medical evaluation for accurate diagnosis.

Diagnostic & Treatment

Diagnosis Path: Diagnosing Hodgkin lymphoma involves several steps: - **Medical history assessment:** Including previous diagnoses and symptoms - **Physical examination:** Checking for swollen lymph nodes - **Imaging tests:** Such as X-rays, CT scans, or PET scans to identify affected areas - **Biopsy:** Removal of tissue from a lymph node for microscopic examination to confirm the presence of Hodgkin (Reed-Sternberg) cells - **Blood tests:** To evaluate overall health and organ function - **Additional tests:** Depending on circumstances, procedures such as bone marrow biopsies may be performed A comprehensive diagnostic approach ensures accurate staging and guides treatment planning.

Treatment Protocols: Treatment options for Hodgkin lymphoma aim to eliminate cancer cells and prevent recurrence. They typically include: - **Chemotherapy:** Use of powerful drugs to target cancer cells, often a combination regimen - **Radiation therapy:** Targeted high-energy rays to destroy affected lymph nodes - **Immunotherapy:** Boosting the body's immune response against cancer cells - **Stem cell transplant:** In some cases, especially in relapsed or refractory disease, to allow high-dose chemotherapy - **Targeted therapy:** Drugs designed to target specific molecules involved in lymphoma growth Treatment plans are tailored based on factors such as the stage of disease, patient age, and overall health. Advances in therapies have significantly improved prognosis for many patients with Hodgkin lymphoma.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z85.71 a billable ICD-10 code?
Yes, Z85.71 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z85.71?
Clinical documentation must specify the nature of Personal history of Hodgkin lymphoma and any associated comorbidities for accurate reporting.

Cite this Clinical Reference